BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18439163)

  • 21. [Possibilities of electrotherapy of the heart in the prehospital phase].
    Volkmann H; Paliege R
    Z Arztl Fortbild (Jena); 1984; 78(15):623-5. PubMed ID: 6495772
    [No Abstract]   [Full Text] [Related]  

  • 22. [Dear readers].
    Butter C; Israel CW
    Herzschrittmacherther Elektrophysiol; 2008 Dec; 19 Suppl 1():5. PubMed ID: 19169729
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of cardiac contractility. A potential treatment of heart failure?
    Daubert JC
    Eur Heart J; 2008 Apr; 29(8):961-3. PubMed ID: 18367493
    [No Abstract]   [Full Text] [Related]  

  • 24. Health status assessment tools: natural components of cardiac resynchronization therapy?
    Anderson KP
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1257-8. PubMed ID: 19732356
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and clinical management of cardiomyopathies and heart failure in China.
    Jiang H; Ge J
    Heart; 2009 Nov; 95(21):1727-31. PubMed ID: 19318343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy.
    Sredniawa B; Lenarczyk R; Kowalski O; Pruszkowska-Skrzep P; Kowalczyk J; Musialik-Lydka A; Cebula S; Kalarus Z
    Europace; 2009 Jan; 11(1):106-14. PubMed ID: 19008239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate-responsive pacing in patients with heart failure: long-term results of a randomized study.
    Nägele H; Rödiger W; Castel MA
    Europace; 2008 Oct; 10(10):1182-8. PubMed ID: 18723519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac-resynchronization therapy.
    Daubert C; Leclercq C
    N Engl J Med; 2008 Apr; 358(17):1865; author reply 1865-6. PubMed ID: 18434658
    [No Abstract]   [Full Text] [Related]  

  • 30. [Non-pharmacologic treatment of cardiac arrhythmias].
    Stoupel E; Schoenfeld P
    Rev Med Brux; 1988; 9(1):4-12. PubMed ID: 3283902
    [No Abstract]   [Full Text] [Related]  

  • 31. AV junctional ablation allowing more effective delivery of cardiac resynchronization therapy in patients with intra- and interatrial conduction delay.
    Herweg B; Ilercil A; Madramootoo C; Ali R; Barold SS
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):685-90. PubMed ID: 18507540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep-disordered breathing in heart failure and the effect of cardiac resynchronization therapy.
    Simantirakis EN; Schiza SE; Siafakas NS; Vardas PE
    Europace; 2008 Sep; 10(9):1029-33. PubMed ID: 18682409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy.
    Shalaby A; El-Saed A; Voigt A; Albany C; Saba S
    Pacing Clin Electrophysiol; 2008 May; 31(5):575-9. PubMed ID: 18439171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using cardiac resynchronization therapy diagnostics for monitoring heart failure patients.
    Adamson PB
    Heart Fail Clin; 2009 Apr; 5(2):249-60. PubMed ID: 19249693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selecting CRT candidates: the value of intracardiac mapping.
    Kautzner J; Peichl P
    Europace; 2008 Nov; 10 Suppl 3():iii106-9. PubMed ID: 18955390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double jolt for heart failure.
    Harv Heart Lett; 2002 May; 12(9):5-6. PubMed ID: 12021014
    [No Abstract]   [Full Text] [Related]  

  • 37. [Electric and surgical treatment of tachycardias].
    Godin JF; Touzeau PY
    Soins Cardiol; 1983 Mar; (1):29-34. PubMed ID: 6554901
    [No Abstract]   [Full Text] [Related]  

  • 38. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scintigraphic blood pool and phase image analysis: the optimal tool for the evaluation of resynchronization therapy.
    Botvinick EH
    J Nucl Cardiol; 2003; 10(4):424-8. PubMed ID: 12900747
    [No Abstract]   [Full Text] [Related]  

  • 40. Stimulation rate and the optimal interventricular interval during cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    van Gelder BM; Meijer A; Bracke FA
    Pacing Clin Electrophysiol; 2008 May; 31(5):569-74. PubMed ID: 18439170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.